Why the study?
Does insulin therapy reduce serum IGFBP-3 protease activity in children with insulin-dependent diabetes mellitus?
Population
Children with untreated insulin-dependent diabetes mellitus (IDDM)
Comparison
Insulin therapy vs Age-matched control pool and baseline…
Design
Cohort
Follow-up
1 month
Authors
Loading...
Insulin initiation was associated with normalized IGFBP-3 protease activity in pediatric IDDM; supports regulatory role but hypothesis-generating pending randomized confirmation.
Does insulin therapy reduce serum IGFBP-3 protease activity in children with insulin-dependent diabetes mellitus?
Insulin therapy in children with IDDM normalizes the initially elevated IGFBP-3 protease activity, suggesting insulin regulates this process.
Bereket et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: